Cargando…
Price differentials of oral triptans in eight European Union countries
Triptans are presently a milestone in the treatment of migraine patients. Because of their effectiveness and safety, they have radically improved migraine treatment but their use has meant a substantial increase in spending for medicines. We thus compared retail prices of triptans in eight European...
Autores principales: | Folino-Gallo, Pietro, Palazzo, Fabio, Stirparo, Giuseppe, De Filippis, Sergio, Martelletti, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag Italia
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611682/ http://dx.doi.org/10.1007/s101940300013 |
Ejemplares similares
-
Discrepancies between European countries and USA and Canada in the availability of triptans and in their licensed clinical properties
por: Stirparo, Giuseppe, et al.
Publicado: (2003) -
Evaluating the economic costs of migraine: interest of a comparative approach
por: Dartigues, Jean François, et al.
Publicado: (2003) -
The EuroMedicines Project
por: Walley, Tom
Publicado: (2003) -
General disease costing principles
por: Sofio, Amalia Donia, et al.
Publicado: (2003) -
Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine
por: Gentile, Giovanna, et al.
Publicado: (2010)